Physician profile
Haley Akin
NPI 1760878524
$1,343.54
in general payments reported to CMS, 2019-2025
22 companies · $297 in 2025
The $297 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.97 · 2020: $137 · 2021: $252 · 2022: $483 · 2024: $138 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $335 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.19 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $371.52 | 2020-2022 | |
| Astellas Pharma US INC | $145.17 | 2024-2025 | Veozah |
| Sage Therapeutics, LLC | $112.70 | 2024-2025 | Zurzuvae |
| Novo Nordisk INC | $79.60 | 2021-2022 | |
| Exeltis, USA INC. | $78.30 | 2021-2025 | Slynd |
| Avion Pharmaceuticals | $70.30 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $67.69 | 2022 | |
| Pfizer INC. | $60.22 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $45.96 | 2021-2022 | |
| Boston Scientific Corporation | $44.29 | 2025 | General - Female Sui |
| Supernus Pharmaceuticals, INC. | $40.19 | 2025 | Qelbree |
| Evofem Biosciences, INC. | $28.70 | 2021 | |
| Hologic Sales and Service, LLC | $25.83 | 2020 | |
| Merck Sharp & Dohme LLC | $25.62 | 2019-2021 | |
| Urovant Sciences INC | $24.92 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $24.34 | 2020 | |
| Sumitomo Pharma America, INC. | $20.07 | 2025 | Myfembree |
| Exact Sciences Corporation | $19.71 | 2024 | Cologuard Collection Kit |
| Shield Therapeutics INC | $17.60 | 2025 | |
| Therapeuticsmd, INC. | $16.89 | 2020 | |
| Tesaro, INC. | $12.01 | 2019 | |
| Lupin INC. | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Akin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.